News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>M Stanley Foresees BABA-W 4QFY25 Cloud Rev. Growth to Become Stock Price Catalyst
BABA-W (09988.HK)(BABA.US) is set to unveil its 4QFY25 results for the period ending March 31, 2025, today (15th). Morgan Stanley’s research report highlighted optimism that ...
Reset
Send
The window will close in 5 seconds
<Research>M Stanley Foresees BABA-W 4QFY25 Cloud Rev. Growth to Become Stock Price Catalyst
Close
Recommend
55
Positive
90
Negative
39
 
 

BABA-W (09988.HK)  -5.200 (-4.034%)    Short selling $846.92M; Ratio 7.148%   (BABA.US)      is set to unveil its 4QFY25 results for the period ending March 31, 2025, today (15th). Morgan Stanley’s research report highlighted optimism that Alibaba Cloud will benefit from robust AI inference demand in China, projecting that the upcoming cloud business revenue growth could serve as the next stock price catalyst.

If Alibaba Cloud’s revenue grows 17%-20% YoY in 4QFY25, it could drive a 1%-3% stock upside, Morgan Stanley estimated. A stronger revenue growth of 20%-25% could lead to a 3%-8% share upside. However, if cloud revenue growth underperforms at about 13%-17%, the broker predicted Alibaba’s stock price could shrink by up to 5%.

Related NewsM Stanley: BABA-W's 4QFY25 CMR Beats; Cloud In Line
Morgan Stanley maintained an Overweight rating on Alibaba’s U.S. shares with a target price of USD180.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-16 12:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.